Jubilant Ingrevia Limited (BOM: 543271)

Market Cap	120.86B
Revenue (ttm)	41.10B
Net Income (ttm)	1.76B
Shares Out	n/a
EPS (ttm)	11.09
PE Ratio	68.85
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Aug 2, 2024

Volume	15,322
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	421.60 - 884.95
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 28, 2025

About Jubilant Ingrevia

Jubilant Ingrevia Limited engages in the life science products and solutions in India, the United States, Europe, China and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition heal...

• Industry: Chemicals and Allied Products
• Founded: 2019
• Employees: 2,283
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543271

Financial Performance

In 2023, Jubilant Ingrevia's revenue was 41.36 billion, a decrease of -13.34% compared to the previous year's 47.73 billion. Earnings were 1.83 billion, a decrease of -40.52%.